Clinical pharmacokinetics of alamifovir and its metabolites
10.1128/AAC.49.5.1813-1822.2005
Saved in:
Main Authors: | Chan, C., Abu-Raddad, E., Golor, G., Watanabe, H., Sasaki, A., Yeo, K.P., Soon, D., Sinha, V.P., Flanagan, S.D., He, M.M., Wise, S.D. |
---|---|
Other Authors: | STATISTICS & APPLIED PROBABILITY |
Format: | Article |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/105057 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Safety and efficacy of alamifovir in patients with chronic hepatitis B virus infection
by: Soon, D.K.W., et al.
Published: (2014) -
Effects of chronic renal failure on the pharmacokinetics of ruboxistaurin and its active metabolite 338522
by: Wise, S., et al.
Published: (2014) -
Effects of chronic renal failure on the pharmacokinetics of ruboxistaurin and its active metabolite 338522
by: Wise, S., et al.
Published: (2011) -
Olanzapine pharmacokinetics are similar in Chinese and Caucasian subjects
by: Sathirakul, K., et al.
Published: (2014) -
Clinical Drug Development - Practical Issues in Clinical Pharmacology Studies
by: Wise, S.D.
Published: (2014)